Electrophysiology catheters market is projected to grow from $4.8 billion in 2025 to $11.8 billion by 2035, expanding at a CAGR of 8.7% during the forecast period. The market growth is strongly driven by the rising global burden of cardiovascular diseases, particularly cardiac arrhythmias, alongside increasing adoption of minimally invasive cardiac procedures. A key macro driver accelerating market expansion is the growing prevalence of cardiovascular diseases worldwide. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, representing nearly 32% of all global deaths.

Cotton seed treatment market is projected to grow from $6.8 billion in 2025 to $12.1 billion by 2035, expanding at a CAGR of 5.9% during the forecast period (2026–2035). The market is witnessing steady growth driven by increasing demand for higher crop productivity, rising pest resistance, and the expansion of sustainable agricultural practices globally.

Cardiac safety services market is projected to grow from $1.08 billion in 2025 to $3.51 billion by 2035, expanding at a CAGR of 12.45% during the forecast period. The growth of this market is strongly linked to the increasing global burden of cardiovascular diseases (CVDs), which is driving demand for cardiac safety assessment in drug development. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths annually, representing nearly 32% of all global deaths. Additionally, data from the U.S. Food and Drug Administration highlights that cardiotoxicity is one of the leading causes of drug attrition in clinical trials, particularly in oncology and central nervous system therapeutics. This has significantly increased the need for Thorough QT (TQT) studies and advanced cardiac monitoring services, ensuring regulatory compliance and patient safety.

Brain implant market was valued at $11.1 billion in 2025 and is projected to reach $24.8 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2026–2035). The increasing global burden of neurological disorders is a key macro driver supporting market demand. According to the World Health Organization, neurological disorders are the leading cause of disability worldwide, affecting over 1 billion people, including conditions such as Parkinson’s disease, epilepsy, and Alzheimer’s disease. This growing disease burden is driving the demand for advanced neuro modulation and implantable brain devices that enable targeted treatment and improved patient outcomes.

Body temperature monitoring device market is projected to grow from $4.25 billion in 2025 to $7.25 billion by 2035, expanding at a CAGR of 5.5% during the forecast period. The market growth is primarily driven by the increasing burden of infectious diseases and the rising adoption of remote patient monitoring technologies across healthcare systems worldwide.

Biotechnology market is projected to grow significantly from $1.5 trillion in 2025 to approximately $4.5 trillion by 2035, registering a robust CAGR of 11.5% during the forecast period (2026–2035). The market expansion is primarily driven by the rapid advancement in biologics, gene therapies, and increasing healthcare demand worldwide.

Biopesticides market is witnessing strong momentum, driven by increasing regulatory pressure on synthetic agrochemicals and rising adoption of sustainable agricultural practices. The market was valued at $10.1 billion in 2025 and is projected to reach $30.8 billion by 2035, growing at a CAGR of 11.8% during the forecast period. The shift toward eco-friendly crop protection solutions is accelerating demand across both developed and emerging agricultural economies.

Biofilms treatment market is projected to grow from $2.86 billion in 2025 to $6.24 billion by 2035, registering a CAGR of 9.1% during the forecast period (2026–2035). The increasing burden of chronic wounds, hospital-acquired infections, and antimicrobial resistance is significantly accelerating demand for advanced biofilm-targeted therapies worldwide.

Aviation market is projected to grow from $212 billion in 2025 to $340 billion by 2035, expanding at a CAGR of 4.8% during the forecast period. The market growth is fundamentally driven by rising global air traffic demand, defense modernization programs, and increasing aircraft replacement cycles across both commercial and military sectors.

Anterior uveitis treatment market size was valued at $0.33 billion in 2025 and is projected to reach $0.62 billion by 2035, growing at a CAGR of 6.4% during the forecast period. The market is witnessing steady expansion due to the increasing burden of ocular inflammatory disorders and rising adoption of targeted ophthalmic therapies across developed and emerging economies. A key macro driver supporting market growth is the rising prevalence of autoimmune diseases, which are strongly linked to anterior uveitis. According to the World Health Organization, rheumatoid arthritis alone affects nearly 14 million people globally, indicating a substantial patient pool vulnerable to inflammatory eye conditions. Additionally, anterior uveitis accounts for 40%–50% of all uveitis cases, making it the most common form of the disease and a major contributor to treatment demand. Furthermore, uveitis is responsible for nearly 10% of blindness cases in the United States, highlighting its clinical significance and the urgent need for effective treatment solutions.